Endra Life SciencesNDRA
13F holders, Q2 2025 (June 30)3holders +1
2new positions
1sold out
$3.51avg. 13F price*
At the end of Q2 2025, 3 institutions reported holding Endra Life Sciences Inc. (NDRA) in their 13F filings, up 1 from Q1 2025. 2 opened new positions and 1 sold out. The largest holders were UBS Group AG ($16K), Northwestern Mutual Wealth Management Co. ($123) and Bank of America Corp. ($21).
- Company
- Endra Life Sciences Inc.
- CUSIP
- 29273B500
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $17K |
| Exits | 1 | $5K |
All 13F filers, Q1 2025 → Q2 2025: 4,732 shares bought and 1,130 shares sold, net +3,602 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| UBS Group AG | 0.00% | New | 4,695 | $16K |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 35 | $123 |
| Bank of America Corp. | 0.00% | Add +50.0% | 6 | $21 |
"% of holder's portfolio" is NDRA's weight in each manager's 13F, not the share of Endra Life Sciences Inc. the manager owns.